Aim: To design a highly specific and sensitive multiplex real-time PCR assay for the differentiation of the pathogen Haemophilus influenzae from its nonpathogenic nearneighbor Haemophilus haemolyticus. Materials & methods: A comparison of 380 Haemophilus spp. genomes was used to identify loci specific for each species. Novel PCR assays targeting H. haemolyticus (hypD) and H. influenzae (siaT) were designed. Results & discussion: PCR screening across 143 isolates demonstrated 100% specificity for hypD and siaT. These two assays were multiplexed with the recently described fucP assay for further differentiation among H. influenzae. Conclusion: The triplex assay provides rapid, unambiguous, sensitive and highly specific genotyping results for the simultaneous detection of hypD and siaT, including fucose-positive H. influenzae (fucP), in a single PCR.
The Gram-negative bacterium Haemophilus influenzae is a frequent commensal of the upper respiratory tract of most healthy children and adults, where it usually resides without incident [1] . Occasionally, this opportunistic pathogen can infect other body sites, leading to potentially lifethreatening diseases. Prior to the introduction of the H. influenzae serotype B (Hib) vaccine, Hib was a common cause of invasive diseases including bacteraemia, cellulitis, epiglottitis, meningitis and pneumonia, with approximately 0.5% of all American children under 5 years of age being affected [2] . The introduction of the Hib vaccine in1985 has led to substantially lower rates of invasive disease caused by H. influenzae.
Unencapsulated or nonserotypeable H. influenzae (NTHi) strains have since emerged as an important yet previously overlooked cause of opportunistic disease, particularly in regions where the Hib vaccine has been widely implemented [3] . NTHi is a common pathogen in the lower respiratory tract in chronic obstructive pulmonary disease and bronchiectasis, where it contributes to disease pathology by promoting chronic inflammation [1] . In children with cystic fibrosis, NTHi is an early colonizer that is associated with impaired mucociliary function, thereby increasing the risk of infection by other H. influenzae strains or pathogenic species [1, 4] . NTHi also causes many other acute and chronic diseases, especially in children, including conjunctivitis, otitis media and sinusitis [5] . In contrast, the closely related species H. haemolyticus, which occupies the same niches as H. influenzae, is generally considered to be nonpathogenic [4] .
Despite its medical importance, correct identification of H. influenzae has proven challenging on both the genotypic and phenotypic levels [4, 6] . Genetically, NTHi undergoes high levels of lateral gene transfer with other species, usually with other Haemophilus spp. but occasionally with other genera [7] [8] [9] [10] . The promiscuity of the NTHi genome has greatly impeded prior attempts to specifically target this species using DNA-based methods, most notably when RESEaRch aRticlE Price, Harris, Spargo et al. future science group attempting to differentiate H. influenzae from H. haemolyticus. Selective microbiological approaches are also nonspecific, with certain nonhemolytic H. haemolyticus strains being indistinguishable from NTHi based on X (hemin) and V (nicotinamide adenine dinucleotide) factor dependency [4] . Accurate identification of NTHi in clinical specimens is important for detection, for guiding appropriate antibiotic administration and for assessing the efficacy of treatments or H. influenzae-targeted vaccines [11] . To combat issues with accurate H. influenzae identification, we recently used a large-scale comparative genomic approach across 246 Haemophilus spp. to delineate H. influenzae from other Haemophilus spp., with subsequent design of a specific assay for H. influenzae [6] . This assay targets fucP, a highly conserved gene that encodes for L-fucose permease, a major facilitator superfamily transporter involved in L-fucose uptake [12] . The fucP gene resides within the fucose operon [13] , which also encodes the multilocus sequencing typing (MLST) 'housekeeping' gene, fucK [14] . However, there is a growing body of evidence that certain H. influenzae strains lack some, or all, genes within the fucose operon [13, [15] [16] [17] . For example, a recent study using multilocus sequence analysis across 60 clinical Haemophilus spp. strains showed high nucleotide similarity of strains both harboring and lacking the fucK locus, suggesting that these strains are genetically related and are in fact the same species [16] . On a phylogenomic level, these 'fuzzy' fucosenegative isolates share a node with 'Clade I' H. influenzae [6] , a genetically distinct cluster of H. influenzae that is nonetheless considered to belong to this species [18] .
Given that the fucP assay excludes fucose-negative H. influenzae, we used our previously described comparative genomics approach [6] to design a new TaqMan assay that encompasses both fucP-positive and fucP-negative H. influenzae strains. We also employed this same approach to develop a H. haemolyticus-specific assay. These two novel assays were combined with the existing fucP TaqMan assay in a triplex format for the simultaneous, specific and sensitive detection of fucose-positive and fucose-negative H. influenzae, and H. haemolyticus.
Methods

•
• Ethics statement
Ethics approval for this study was obtained as detailed previously [6] .
•
• Haemophilus genomes
A total of 380 Haemophilus spp. genomes were available for this study: 316 H. influenzae (145 generated in the current study, 19 unpublished and 152 published elsewhere [6, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] ), 59 H. haemolyticus (44 generated in the current study, one unpublished and 14 published elsewhere [6, 26, 28, [35] [36] Table 1 ). The hypD assay differentiates H. haemolyticus (red) from all other species and the siaT assay differentiates H. influenzae (blue), 'Clade I' H. influenzae (purple) and fucose operon-negative H. influenzae strains (green) from all other species. The fucP assay [6] was designed to differentiate fucose operonpositive H. influenzae (blue) and 'Clade I' H. influenzae (purple) [18] from all other species. However, we uncovered three isolates in the 'conventional' H. influenzae clade (grey shading) that are fucP-negative by PCR and in silico. Consistency index = 0.10. The comparative genomics tool SPANDx v2.7 [37] was used to perform phylogenetic reconstruction of 375 H. influenzae and H. haemolyticus genomes, using default settings. The H. parainfluenzae genomes were excluded from phylogenetic analysis due to relative genetic dissimilarity. Four isolates (839_HINF, C1, F0397 and 614_HPAR) were reassigned their original species designation based on our phylogenetic analysis, which confidently placed them as belonging to either H. haemolyticus (839_HINF, C1, F0397) or H. influenzae (614_HPAR; Figure 1) . Following phylogenetic reconstruction, SPANDx was rerun with the inclusion of the H. parainfluenzae genomes to identify genetic loci specific to H. influenzae, including the fucP-negative clade, and to H. haemolyticus, as described previously [6] . Reads were mapped against the closed reference genome H. influenzae 86-028NP (GenBank ref: NC_007146) [22] and the draft H. haemolyticus genome M19501 (GenBank ref: NZ_AFQN00000000) [35] .
• hypD & siaT real-time PCR assay design
Due to high sequence diversity among both H. influenzae and H. haemolyticus genomes, we chose the TaqMan TM minor groove binding probe (MGB; Applied Biosystems, CA, USA) format for species detection. The MGB moiety raises the melting temperature of the probes, enabling the design of shorter probes that mitigate issues of potential sequence diversity in longer probes. TaqMan MGB probes also exhibit high sensitivity and specificity in a background of high noise, such as clinical specimens [38] , and the availability of nonfluorescent quenchers and multiple fluorogenic detector dyes permits multiplexing [39] . To detect H. haemolyticus, the following primers and TaqMan MGB probe were designed: hypD-F (5′-GGCA ATCAGATGGTTTACA ACG), hypD-R (5′-CAGCTTA A AGYA AGYAGTGA ATG; Macrogen Inc., Geumcheon-gu, Seoul, Rep. of Korea) and hypD-Probe (5′-V IC-CCACAACGAGAATTAG-MGBNFQ; Applied Biosystems). For H. influenzae detection, siaTFor (5′-AATGCGTGATGCTGGTTATGAC) and siaT-Rev (5′-AAGAGTTTTGCGATAGA TTCATTGG) were used in combination with siaT-Probe (TET-AGAAGCAGCAGTAATT-MGBNFQ). The siaT and hypD assays generate 138 bp and 187 bp amplicons, respectively. The 68 bp fucP assay, which uses a 6FAM™-labelled TaqMan probe (Applied Biosystems) for increased specificity, was included with hypD and siaT in a triplex assay format for the simultaneous detection of H. influenzae (including fucose operon-negative H. influenzae) and H. haemolyticus in a single reaction.
Amplicon specificity for hypD and siaT was confirmed using microbial discontiguous MegaBL AST analysis ([40] ; performed 8 February 2016) across 3992 complete microbial genomes, 29,229 draft microbial genomes, 2078 complete plasmid genomes and 1988 complete bacteriophage genomes (total: 37,287 genomes). A nonredundant nucleotide (nr/nt) collection BLAST search was also conducted to determine amplicon specificity in nonmicrobial genomes.
• Triplex real-time PCR conditions
PCRs were performed using an ABI PRISM ® 7900HT instrument (Life Technologies, VIC, Australia) in 384-well optical plates (Life Technologies). Following optimization in singleplex format, the three assays were merged into a triplex format. Each reaction contained 0.25 μM of fucP, 0.3 μM siaT and 0.15 μM hypD primers, 0.1 μM of the fucP, 0.2 μM of the siaT and 0.2 μM of the hypD TaqMan MGB probes, 1 μl genomic DNA, 1× Platinum ® PCR SuperMix (Life Technologies), 0.5 μM ROX™ reference dye (Life Technologies) and molecular-grade water, to a total volume of 5 μl. All samples were run in duplicate, and all runs contained positive and no-template controls. Thermocycling was conducted as previously described [6] . The FAM, TET and VIC channels were used for simultaneous fluorescence detection of fucP, siaT and hypD, respectively. To determine the lower limit of quantitation (LOQ) for the fucP, siaT and hypD assays in the triplex format, we performed a standard curve analysis comprising 16 replicates tested across 1:10 serial dilutions, with the template concentrations ranging from 2 to 2 × 10 -8 ng. H. influenzae ATCC 49247 was used as the control for fucP and siaT, and H. haemolyticus future science group www.futuremedicine.com ATCC 33390 the control for hypD. LOQ values were determined for each assay based on previously described criteria [41] , with minor modifications. Briefly, replicates at a given dilution with a cycles to threshold (C T ) standard deviation (σ) of ≥0.8 were considered to exceed the LOQ, with one or more amplification failures also deemed a LOQ failure. The upper LOQ value was not determined due to the unlikelihood of encountering such high-pathogen DNA concentrations in clinical specimens.
Results & discussion
• Phylogenomic analysis of Haemophilus spp. for species determination
To accurately delineate Haemophilus spp., we first constructed a genome-wide phylogenetic tree. We have previously employed this approach across 63,447 core genome, biallelic single-nucleotide polymorphisms (SNPs) identified among 246 Haemophilus spp. genomes [6] .
In the current study, we expanded our dataset to include recently published H. influenzae and H. haemolyticus genomes. This updated analysis identified 56,187 core genome, biallelic SNPs among 375 Haemophilus spp. genomes, and again revealed a clear delineation between H. influenzae and H. haemolyticus (Figure 1) . Fewer SNPs were found in this re-analysis due to the reduction in the core genome as a consequence of the additional 127 taxa. We used this phylogeny to reclassify species designations for strain 839_HINF from H. influenzae to H. haemolyticus, strains C1 and F0397 from Haemophilus spp. to H. haemolyticus and strain 614_HPAR from H. parainfluenzae to H. influenzae (Supplementary Table 1 ). The species misclassification of these strains by the original authors [28] exemplifies the difficulties associated with accurate speciation of Haemophilus spp. Other researchers [13, [15] [16] have reported that certain H. influenzae isolates may lack fucK, one of the seven genes used in the H. influenzae MLST scheme [14] . The absence of this gene has historically confounded H. influenzae speciation attempts such as the probable incorrect assignment of fucK-negative H. influenzae strains as H. haemolyticus [42] . The fucK gene is encoded in the same operon as fucP; thus, isolates lacking fucK largely, if not exclusively, also lack fucP [6] . On the genome level, most fucP-negative H. influenzae strains reside in a distinct, genetically distant lineage that separates them from conventional fucP-positive H. influenzae strains by several thousand SNPs [6] . This genomic dissimilarity between fucP-negative and conventional fucP-positive strains previously led us to also propose that fucP-negative strains, while closely related to H. influenzae, might comprise a novel 'fuzzy' Haemophilus species [6] . However, this distance RESEaRch aRticlE Price [18] , at the time the largest comparative genomic analysis of H. influenzae. We have since shown that Clade I H. influenzae and fucP-negative strains share a node [6] , implying that they have shared ancestry. These 'fuzzy' isolates should therefore be considered fucose-negative H. influenzae. Although it is unfortunate that the developers of the H. influenzae MLST scheme inadvertently chose a variably present gene for their scheme, our genomic approach confirms the suspicion that many in the Pasteurellaceae research community have had for some time regarding the existence of fucose-negative H. influenzae strains. Redesign of the existing H. influenzae MLST scheme to incorporate a conserved seventh locus in H. influenzae and H. haemolyticus in place of fucK will lead to greater uptake of this highly useful genotyping scheme globally.
The novel siaT assay developed in the present study should be used to identify all H. influenzae strains. Although we can no longer recommend the use of the fucP (or fucK ) gene for identification of H. influenzae, this assay still has utility for differentiating fucP-positive and fucP-negative H. influenzae, and for confirming siaT-positive isolates and clinical specimens. Future studies focused on the relative abundance of fucP-positive and fucP-negative H. influenzae strains may uncover previously undetected associations with certain types of NTHi-associated disease. In addition, the inclusion of the hypD assay in the triplex PCR enables unambiguous detection and assignment of suspected H. haemolyticus strains.
• • Fucose operon-negative H. influenzae comprise several lineages We identified three 'conventional' H. influenzae isolates from our Australian isolate collection that lack fucP (isolates 65373 BAL Hi-3, 65234 BAL Hi-2 and 65234 NP Hi-1; Figure 1 ). This finding demonstrates that there is an imperfect association between the fucP-negative H. influenzae and 'conventional' H. influenzae clades, a phenomenon that has also been reported by LaCross et al. [17] . The small number of fucP 'failures' highlights the inherent difficulties associated with Haemophilus spp. identification, and consolidates our previous assertion that no single genetic target is likely to be 100% diagnostic for a given species due to high levels of active recombination occurring within and among strains [6] . Nevertheless, we show that, for now at least, the siaT and hypD assays provide 100% specificity for H. influenzae and H. haemolyticus across our dataset. Given the high risk of eventually identifying siaT hypD false positives and false negatives, the development of further species-specific assays for H. influenzae and H. haemolyticus is encouraged. Future H. influenzae or H. haemolyticus studies should use such redundancy for accurate species determination, with comparative phylogenomic analysis used as the 'gold standard' method for species assignment wherever possible.
Conclusion
We have used comparative genomics to identify robust species-specific markers for H. influenzae (siaT ) and its closest near-neighbor, H. haemolyticus (hypD). These assays were tested across a panel of 143 Haemophilus and non-Haemophilus spp., where they demonstrated 100% specificity and sensitivity. Multiplexing these newly developed assays with the previously developed fucP assay allowed further differentiation among H. influenzae. The lower LOQ was determined as ten genome equivalents for H. influenzae templates (siaT and fucP) and 100 genome equivalents for H. haemolyticus (hypD). This triplex assay is recommended for studies where accurate speciation of H. influenzae and H. haemolyticus is required; the fucP assay can be omitted where the identification of fucose-negative H. influenzae strains is not sought. One recognized limitation of this study is that we only tested the triplex assay on DNA extracted from purified colonies. Future work should focus on examining the robustness and sensitivity of these assays in the clinical setting and on clinical specimens from various regions.
Future perspective
Comparative genomics is rapidly advancing our understanding of infectious diseases. As nextgeneration sequencing technologies improve, these methods will see even greater implementation in laboratories worldwide. Nevertheless, PCR-based methods remain an attractive option for sensitive, specific and rapid species identification due to their relatively low cost, speed and ease-of-use. Direct testing of clinical samples for the presence of H. influenzae and future science group www.futuremedicine.com H. haemolyticus will provide further insights into the contribution of these bacteria in human infectious diseases and will enable the use of more targeted, narrow-spectrum antibiotics.
